Skip to content

A clinical trial comparing , Bupivacaine (local anesthetic )injection on either side of neck of uterus and vaginal stump left behind after total laparoscopic uterus removal versus vaginal stump injection of bupivacaine alone in reducing postoperative pain after total laparoscopic uterus removal.

A randomized controlled trial comparing the efficacy of Bupivacaine injection in vaginal vault and para-cervical region vs vaginal vault infiltration with Bupivacaine after Total Laparoscopic Hysterectomy.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/10/028207
Enrollment
30
Registered
2020-10-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified Health Condition 2: N859- Noninflammatory disorder of uterus, unspecified Health Condition 3: N925- Other specified irregular menstruation

Interventions

Intervention1: vault infiltration: vault infiltration with 10 ml of 0.5 % Bupivacaine. Control Intervention1: Para cervical block with vault infiltration: para cervical block with 10 ml of 0.5 % Bupiv

Sponsors

All India Institute Of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Benign Gynecological conditions. 2.With or without salpingo oophorectomy. 3.Consenting women

Exclusion criteria

Exclusion criteria: 1.Extensive additional tissue manipulation during surgery 2.Undue prolonged surgeries 3.Gynecological malignancies 4.Conversion to laparotomy 5.History of PID 6.Known allergy to amide anesthetics 7.Women not consenting to participate in the study

Design outcomes

Primary

MeasureTime frame
Visual Analog Scale of painTimepoint: 1 hour

Secondary

MeasureTime frame
visual analog scale of painTimepoint: 2 hours and 6 hours

Countries

India

Contacts

Public ContactDr Kaloni Subramani

AIIMS , New Delhi

drkkroy2003@gmail.com9811317011

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026